Increasing Trend of Minimally Invasive Procedures Fuels Global Hemostasis and Tissue Sealing Agents Market

Published By : 11 Jan 2016 | Published By : QYRESEARCH

The global market for hemostasis and tissue sealing agents has been showing impressive growth, thanks to the rising trend of minimally invasive processes in the global arena. Many international companies are focusing on emerging economies owing to their untapped potential in the field of hemostasis and tissue sealing agents. Here is a snapshot of the latest movements, influencing the worldwide hemostasis and tissue sealing agents market.

  • The topical hemostats segment leads the global hemostasis and tissue sealing agents product market. The widespread adoption of topical hemostats, specifically active hemostats, in surgical processes is the main driving force behind this rise.
  • Active hemostats are highly efficient in limiting excessive bleeding. This property has stimulated the demand for active hemostats significantly, owing to which, the segment is likely to post the highest growth rate in the coming years among all the topical hemostats market segments.
  • The adhesive and tissue sealing agents market has occupied a share of around 40% in the overall product market. The natural tissue sealant segment dominates the overall market for adhesive and tissue sealing agent. The abundant availability of natural tissue sealants commercially such as TachoSil, Floseal, and Tisseel is the key reason for the growth of this market segment.
  • North America is the leading regional market for hemostasis and sealing agents across the world. It has acquired a share of approximately 36% in the overall market. The increasing number of patients, who require to stay in observation after surgical procedures for a longer period, is boosting the hemostasis and sealing agents in North America.
  • Europe has occupied the second position in the global hemostasis and tissue sealing agents market. The continual growth in the geriatric population base is propelling the demand of hemostasis and tissue sealing agents to a significant extent in this region.
  • Asia Pacific is projected to register the fastest rise in the coming years due to the growing investment from major market participants in this region.

Cohera Medical, Pfizer, Johnson & Johnson, CryoLife, C.R. Bard, Integra LifeSciences Corp., Advanced Medical Solutions Group, and Baxter are the key producers of hemostasis and tissue sealing agents across the world.

Back To Top